BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11901534)

  • 1. Diabetes mellitus and the risk of prostate cancer.
    Rosenberg DJ; Neugut AI; Ahsan H; Shea S
    Cancer Invest; 2002; 20(2):157-65. PubMed ID: 11901534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between coronary heart disease and cancers of the breast, prostate, and colon.
    Neugut AI; Rosenberg DJ; Ahsan H; Jacobson JS; Wahid N; Hagan M; Rahman MI; Khan ZR; Chen L; Pablos-Mendez A; Shea S
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):869-73. PubMed ID: 9796631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of diabetes mellitus and risk of prostate cancer in physicians.
    Zhu K; Lee IM; Sesso HD; Buring JE; Levine RS; Gaziano JM
    Am J Epidemiol; 2004 May; 159(10):978-82. PubMed ID: 15128610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasectomy and prostate cancer: a case-control study in India.
    Platz EA; Yeole BB; Cho E; Jussawalla DJ; Giovannucci E; Ascherio A
    Int J Epidemiol; 1997 Oct; 26(5):933-8. PubMed ID: 9363512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer risk among men with diabetes mellitus (Spain).
    González-Pérez A; García Rodríguez LA
    Cancer Causes Control; 2005 Nov; 16(9):1055-8. PubMed ID: 16184470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.
    Ohwaki K; Endo F; Shimbo M; Fujisaki A; Hattori K
    Aging Male; 2017 Dec; 20(4):257-260. PubMed ID: 28332895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.
    Kuo YJ; Sung FC; Hsieh PF; Chang HP; Wu KL; Wu HC
    Cancer Med; 2019 May; 8(5):2514-2523. PubMed ID: 30968600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
    Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
    World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Variation in Time to Prostate Biopsy After an Elevated Screening Level of Serum Prostate-specific Antigen.
    Reading SR; Porter KR; Hsu JY; Wallner LP; Loo RK; Jacobsen SJ
    Urology; 2016 Oct; 96():121-127. PubMed ID: 27316374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.
    Raval AD; Mattes MD; Madhavan S; Pan X; Wei W; Sambamoorthi U
    J Diabetes Res; 2016; 2016():2656814. PubMed ID: 27547763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasectomy and prostate cancer: a case-control study in a health maintenance organization.
    Zhu K; Stanford JL; Daling JR; McKnight B; Stergachis A; Brawer MK; Weiss NS
    Am J Epidemiol; 1996 Oct; 144(8):717-22. PubMed ID: 8857819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiologic correlations of prostate cancer in Guangdong, China to family history of cancers, and sexual and marital factors-a case-control study].
    Liang CH; Liu Q; Zhou FJ; Gao X; Chen LW
    Ai Zheng; 2007 May; 26(5):484-8. PubMed ID: 17672937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
    Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
    Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan.
    Sidney S; Quesenberry CP; Sadler MC; Guess HA; Lydick EG; Cattolica EV
    Am J Epidemiol; 1991 Oct; 134(8):825-9. PubMed ID: 1719806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and the risk of prostate cancer in Italy.
    Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
    Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
    Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
    Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.